Onco-Innovations Limited (CVE:ONCO) | Finanzwire

Basculer en Français

9475	Companies
185451	Keywords
117789	Articles
99301	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 05/23/2025 at 00:05, 6 months 13 days ago

Onco-Innovations Welcomes Professor Steven Jones as Senior Scientific Advisor

Precision Medicine Scientific Leadership Cancer Genomics AI-Powered Oncology Steven Jones
PRESS RELEASE

published on 05/23/2025 at 00:00, 6 months 13 days ago

Onco-Innovations Announces Appointment of Professor Steven Jones as Senior Scientific Advisor, Strengthening Technical Acumen in AI-Powered Precision Oncology
Onco-Innovations appoints Professor Steven Jones as Senior Scientific Advisor to advance precision oncology through AI-powered solutions

Precision Oncology AI-powered Solutions Genomics Onco-Innovations Professor Steven Jones
BRIEF

published on 05/17/2025 at 00:05, 6 months 19 days ago

Onco-Innovations to List Shares on Cboe Canada

Stock Exchange Oncology Investor Engagement Onco-Innovations Cboe Canada
PRESS RELEASE

published on 05/17/2025 at 00:00, 6 months 19 days ago

Onco-Innovations Celebrates Listing of Common Shares on Cboe Canada
Onco-Innovations Limited to transfer listing of Common Shares to Cboe Canada from CSE; trading on Cboe Canada begins on May 22, 2025. Company aims for investor trust, liquidity, and visibility under existing ticker symbol 'ONCO'

Common Shares Listing Transfer Onco-Innovations Limited Cboe Canada Investor Trust
BRIEF

published on 04/25/2025 at 00:05, 7 months 10 days ago

Onco-Innovations' Inka Health Partners with AstraZeneca Canada

Real-world Evidence Onco-Innovations Inka Health AstraZeneca Canada Drug Submission
PRESS RELEASE

published on 04/25/2025 at 00:00, 7 months 10 days ago

Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science
Onco-Innovations Limited's subsidiary, Inka Health Corp., partners with AstraZeneca Canada for real-world evidence research in oncology. The new engagement showcases Inka Health's expertise in evidence translation and market access

Oncology Onco-Innovations Limited Inka Health Corp. AstraZeneca Canada Real-world Evidence Research
BRIEF

published on 04/18/2025 at 00:05, 7 months 17 days ago

Onco-Innovations Partners with Dalton Pharma for PNKP Isotope Synthesis

Cancer Research Onco-Innovations PNKP Technology Dalton Pharma Services ADME Studies
PRESS RELEASE

published on 04/18/2025 at 00:00, 7 months 17 days ago

Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
Onco-Innovations partners with Dalton Pharma Services to synthesize heavy labelled PNKP inhibitor for increasing survival rate in colorectal cancer mice. Study showcases promising therapeutic potential

Colorectal Cancer Survival Rate Onco-Innovations Dalton Pharma Services PNKP Inhibitor
BRIEF

published on 04/17/2025 at 01:35, 7 months 18 days ago

Onco-Innovations Plans $600,000 Private Placement

Private Placement Warrants Regulatory Approval Securities Offering Corporate Funding
PRESS RELEASE

published on 04/17/2025 at 01:30, 7 months 18 days ago

Onco-Innovations Announces Private Placement
Onco-Innovations Limited announces a non-brokered private placement of up to 400,000 units at $1.50 per unit, for gross proceeds of up to $600,000, with plans for cancer research and treatment advancements

Private Placement Securities Oncology Cancer Research Onco-Innovations Limited

Accesswire

Published on 12/05/2025 at 02:35, 9 hours 51 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 9 hours 56 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 11 hours 26 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 21 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 26 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 12:05, 21 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 26 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 26 minutes ago

Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 12 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 1 hour 56 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX

Les Echos

Published on 12/05/2025 at 08:45, 3 hours 41 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 18 hours 26 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 18 hours 41 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 18 hours 42 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 5 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE